Rare Disease CROs in India
8 published
8 published CROs match Rare Disease in India.
Facilities in this set are in Bengaluru, Hyderabad, Ahmedabad, Mallapur, New Delhi, and Pune.
Capabilities that show up most often in this set: Biostatistics & Statistical Programming, Data Management & eClinical, Regulatory Affairs, China NMPA Regulatory Strategy, and Japan PMDA Regulatory Strategy.
Matching companies
Aragen Life SciencesGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
ICON plcICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
PHARMA-STATSSpecialist biostatistics CRO offering full-service and embedded FSP statistical support, with adaptive trial design, survival analysis, and regulatory query consulting. Validated R-based analyses target oncology, rare disease, and bioequivalence work.
PPDPPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.
PerceptiveLeading clinical research organization providing preclinical to late-phase imaging, randomization and trial supply management (RTSM), and eClinical services to the global biopharmaceutical industry.
Premier ResearchPremier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
WeltrixBiometrics CRO for emerging and mid-size biotech sponsors, covering biostatistics, SAS and R programming with CDISC SDTM/ADaM datasets, and clinical data management. Regulatory support spans FDA and DCGI submissions, including IND, NDA, and BLA planning.
Markdown mirror: /indications/rare-disease/india.md